相关实验视频
Updated: Sep 10, 2025

10:42
A Free-breathing fMRI Method to Study Human Olfactory Function
Published on: July 30, 2017
9.7K
嗅觉指导行为揭示了阿尔茨海默病风险的成像和分子特征
Hae Sol Moon1,2, Zay Yar Han1, Robert J Anderson1,3
1Quantitative Imaging and Analysis Laboratories, Radiology Department, Duke University Medical Center, Durham, NC 27710, USA.
Brain sciences
|August 28, 2025
概括
嗅觉障碍可能是阿尔茨海默病 (AD) 风险的信号. APOE4小鼠的嗅觉和记忆力更差,特别是在高脂肪饮食中,突出了早期的AD生物标志物.
科学领域:
- 神经科学
- 遗传学
- 生物标志物发现
背景情况:
- 嗅觉功能障碍可能是阿尔茨海默病的早期指标.
- 与AD遗传和环境风险相关联的机制尚未完全理解.
- 人性化APOE小鼠模型提供了一个研究AD风险因素的平台.
研究的目的:
- 确定早期阿尔茨海默病风险的生物标志物.
- 研究与阿尔茨海默病风险相关的大脑网络变化.
- 探索APOE基因型,饮食和年龄对嗅觉功能和AD病理的影响.
主要方法:
- 多模式分析包括嗅觉行为,扩散MRI连接学和脑/血液转录学.
- 在不同的饮食和免疫条件下对APOE2,APOE3和APOE4基因型的小鼠进行评估.
- 统计分析包括ANOVA和弹性网调节的多集规范相关性分析 (MCCA).
主要成果:
- APOE4小鼠表现出加速的嗅觉和记忆缺陷,由高脂肪饮食加剧,而APOE2小鼠表现出弹性.
- 年龄和饮食显著加剧了行为障碍.
- MCCA确定了与嗅觉行为差异相关的脑子子网络 (腹腔轨道,体感皮层).
- 血液转录组与大脑成像变化相关, 显示了外围分子相关性.
结论:
- 嗅觉行为是AD风险的敏感,可翻译的生物标志物,受遗传和环境因素的影响.
- 综合系统层面的方法揭示了阿尔茨海默氏症早期感官认知脆弱性的大脑和血液特征.
- 这些发现支持早期阿尔茨海默病发现和干预策略的新途径.
相关概念视频
Olfaction
45.1K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
45.1K
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666

